News-Morimatsu LifeSciences

FROM CRITICAL EQUIPMENT TO
TOTAL PROCESS SOLUTION

BACK

Morimatsu LifeSciences Achieves SBTi Validation, Strengthening Its Decarbonization Roadmap with Science-Based Targets

Morimatsu LifeSciences is pleased to announce that its near-term, long-term, and net-zero greenhouse gas (GHG) emissions reduction targets have been officially validated by the Science Based Targets initiative (SBTi). This milestone reflects the company's commitment to addressing climate change
The Path to Digital and Intelligent Compliance in Pharmaceutical Equipment Asset Management: Practical Implementation and Continuous Advancement Under the New ISO 55000/55001 Standards

The 2024 editions of ISO 55000 and ISO 55001, released by ISO/TC 251, fully replace the previous versions and mark a significant step forward in the practical, digital, and compliance-driven implementation of asset management systems. The updated standards place greater emphasis on core elements suc
Invitation Letter | Pharmadule Morimatsu Invites You to Join Us at BIO International Convention

✨We‘re excited to announce our participation in BIO International Convention.📅 Date: 22-25 June, 2026📍 Venue: San Diego, USA🎯 Booth: 5920Join our team to discover the latest innovations for the biopharmaceutical industry. We invite you to drop by and explore in-depth technical discussion wit
WuXi Biologics Marks Successful Topping-Out of Modular DP Facility Supported by Pharmadule Morimatsu

On June 5, 2026, WuXi Biologics marked a major milestone at its Singapore manufacturing site with the successful topping-out of all the main modules of its new modular drug product (DP) facility, a project in collaboration with Pharmadule Morimatsu. This achievement lays a strong foundation for the
Invitation Letter | Pharmadule Morimatsu Invites You to Join Us at Bioproduction A3P & MabDesign

🔔 We are glad to announce that we are attending the Bioproduction A3P & MabDesign！📅 Date: 2-3 June, 2026📍 Venue: Movenpick, Lausanne, Switzerland🎯 Booth: 3This is a key meeting point for professionals driving the development and industrialization of biopharmaceuticals. We look forward t

Prev 1 2 3 4 5··· Next